medroxyprogesterone has been researched along with Adenocarcinoma Of Kidney in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (69.23) | 18.7374 |
| 1990's | 5 (19.23) | 18.2507 |
| 2000's | 3 (11.54) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bay, JO; Caty, A; Chevreau, C; Delva, R; Escudier, B; Negrier, S; Perol, D; Ravaud, A; Sevin, E | 1 |
| Wittes, J | 1 |
| Altman, DG; Parmar, MK; Royston, P | 1 |
| Bach, D; Romics, I; Rüssel, C | 1 |
| Falk, W; Halama, J; Halama, JM | 1 |
| Blyth, B; deKernion, JB; Neuwirth, H; Richie, AW; Taube, DM | 1 |
| Akimoto, M; Hara, M; Hasegawa, J; Kawamura, N | 1 |
| Achtnich, U; Arvidsson, A; Borgström, E; Carbin, BE; Esposti, PL; Näslund, I; Söderlund, V; Steineck, G; Strander, H; Wallin, L | 1 |
| Imai, K; Ito, Y; Kobayashi, M; Nagata, M; Nakai, K; Suzuki, T; Yamanaka, H | 1 |
| Ljungberg, B; Nilsson, TK; Tomic, R | 1 |
| Diem, U; Fritz, U; Müller, GA; Waller, HD; Walter, E | 1 |
| Ljungberg, B; Roos, G; Tomić, R | 1 |
| Chaitchik, S; Laufer, R; Merimsky, O | 1 |
| Drucker, DJ; Goss, P; Siminoski, K | 1 |
| Cozzoli, A; Di Fronzo, G; Dormia, E; Fontanella, U; Giongo, A; Longo, G; Minervini, S; Piva, L; Pizzocaro, G; Zanollo, A | 1 |
| Yamashita, S | 1 |
| Di Fronzo, G; Miodini, P; Piva, L; Pizzocaro, G; Ronchi, E; Salvioni, R | 1 |
| Ieda, K; Matsuzaki, S; Nagakura, K; Takao, M | 1 |
| Decensi, A; Pavesi, L; Prada, GA; Preti, P; Robustelli della Cuna, G; Zanon, P | 1 |
| Hasford, J; Messerer, D; Neiss, A; Porzsolt, F | 1 |
| Aulitzky, W; Gottwald, A; Hautmann, R; Messerer, D; Moormann, JG; Porzsolt, F; Rasche, H; Schumacher, K; Sparwasser, H; Stockamp, K | 1 |
| Damber, JE; Ljungberg, B; Tomić, R | 2 |
| Amin, R | 1 |
| Crawford, ED; Gottesman, JE; Grossman, HB; McCracken, JD; Scardino, P | 1 |
| Foret, JD; Jewell, WR; Krishnan, EC; Mebust, WK; Noble, MJ; Votapka, T; Weigel, JW | 1 |
1 review(s) available for medroxyprogesterone and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
An overview of clinical trials with high-dose medroxyprogesterone acetate (HD-MPA) in endocrine-related tumors other than breast cancer.
Topics: Administration, Oral; Carcinoma, Renal Cell; Clinical Trials as Topic; Diethylstilbestrol; Female; Humans; Injections, Intramuscular; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Ovarian Neoplasms; Prostatic Neoplasms; Uterine Neoplasms | 1986 |
8 trial(s) available for medroxyprogesterone and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Medroxyprogesterone, interferon alfa-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis: results of a randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Disease-Free Survival; Female; Humans; Interferon alpha-2; Interferon-alpha; Interleukin-2; Kidney Neoplasms; Male; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Prognosis; Quality of Life; Recombinant Proteins; Survival Rate; Treatment Outcome | 2007 |
Visualizing length of survival in time-to-event studies: a complement to Kaplan-Meier plots.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Disease-Free Survival; Humans; Interferons; Kaplan-Meier Estimate; Kidney Neoplasms; Medroxyprogesterone; Prognosis; Proportional Hazards Models | 2008 |
Recombinant leukocyte interferon alpha-2a and medroxyprogesterone in advanced renal cell carcinoma. A randomized trial.
Topics: Adult; Aged; Carcinoma, Renal Cell; Female; Humans; Interferon alpha-2; Interferon Type I; Interferon-alpha; Kidney Neoplasms; Liver; Male; Medroxyprogesterone; Middle Aged; Randomized Controlled Trials as Topic; Recombinant Proteins | 1990 |
Adjuvant medroxyprogesterone acetate to radical nephrectomy in renal cancer: 5-year results of a prospective randomized study.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Clinical Trials as Topic; Combined Modality Therapy; Female; Gonadal Steroid Hormones; Humans; Kidney; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Nephrectomy; Prospective Studies; Random Allocation; Receptors, Cell Surface | 1987 |
Adjuvant medroxyprogesterone acetate and steroid hormone receptors in category M0 renal cell carcinoma. An interim report of a prospective randomized study.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Clinical Trials as Topic; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Kidney; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Nephrectomy; Prospective Studies; Random Allocation; Receptors, Steroid; Tamoxifen; Time Factors | 1986 |
An overview of clinical trials with high-dose medroxyprogesterone acetate (HD-MPA) in endocrine-related tumors other than breast cancer.
Topics: Administration, Oral; Carcinoma, Renal Cell; Clinical Trials as Topic; Diethylstilbestrol; Female; Humans; Injections, Intramuscular; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Ovarian Neoplasms; Prostatic Neoplasms; Uterine Neoplasms | 1986 |
[Advantages and problems of multicenter therapy studies exemplified by a study of the treatment of metastasizing renal cell carcinoma with recombinant interferon-alpha-2c].
Topics: Carcinoma, Renal Cell; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Interferon Type I; Kidney Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Random Allocation; Recombinant Proteins | 1987 |
Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate. A randomized multicenter trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Clinical Trials as Topic; Female; Humans; Interferon Type I; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prognosis; Random Allocation; Recombinant Proteins | 1988 |
18 other study(ies) available for medroxyprogesterone and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Times to event: why are they hard to visualize?
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Disease-Free Survival; Humans; Interferons; Kaplan-Meier Estimate; Kidney Neoplasms; Medroxyprogesterone; Odds Ratio; Prognosis; Randomized Controlled Trials as Topic; Research Design; Software | 2008 |
Experience with hormone receptors in renal cancer.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Humans; Kidney; Kidney Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Cell Surface | 1990 |
[Long-term results in the treatment of 100 metastatic hypernephroid carcinomas].
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Combined Modality Therapy; Female; Humans; Kidney Neoplasms; Lymph Node Excision; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Nephrectomy; Postoperative Care; Radiotherapy; Time Factors | 1990 |
Re: Deoxyribonucleic acid content and medroxyprogesterone acetate treatment in metastatic renal cell carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; DNA, Neoplasm; Humans; Kidney Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate | 1990 |
[Therapy on pulmonary metastasis of renal cell carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Combined Modality Therapy; Female; Humans; Immunologic Factors; Interferon Type I; Interleukin-2; Kidney Neoplasms; Lung Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Tegafur; Uracil | 1990 |
[Therapy of renal cell carcinoma. 1. Hormonal therapy].
Topics: Adult; Aged; Carcinoma, Renal Cell; Chlormadinone Acetate; Combined Modality Therapy; Female; Humans; Kidney Neoplasms; Male; Medroxyprogesterone; Middle Aged; Neoplasm Staging | 1985 |
Effects of high dose medroxyprogesterone acetate treatment on antithrombin III and other plasma proteins in males with renal cell or prostatic carcinoma.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antithrombin III; Blood Proteins; Carcinoma, Renal Cell; Delayed-Action Preparations; Haptoglobins; Humans; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Prostatic Neoplasms | 1989 |
[Spontaneous remission of lung metastases in renal cell carcinoma].
Topics: Carcinoma, Renal Cell; Combined Modality Therapy; Humans; Kidney Neoplasms; Lung; Lung Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Nephrectomy; Postoperative Care; Progesterone Congeners; Prognosis; Radiography; Radiotherapy Dosage; Remission, Spontaneous; Time Factors | 1989 |
Deoxyribonucleic acid content and medroxyprogesterone acetate treatment in metastatic renal cell carcinoma.
Topics: Aneuploidy; Antineoplastic Agents; Carcinoma, Renal Cell; Diploidy; DNA, Neoplasm; Female; Flow Cytometry; Follow-Up Studies; Humans; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged | 1989 |
Metastatic renal cell carcinoma arising in a congenital solitary kidney. Treatment with interferon-containing combinations. A case report and a review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Humans; Interferon Type I; Kidney; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Recombinant Proteins; Vinblastine | 1989 |
The Cushing syndrome induced by medroxyprogesterone acetate.
Topics: Adrenocorticotropic Hormone; Adult; Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Cushing Syndrome; Female; Humans; Hydrocortisone; In Vitro Techniques; Kidney Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Pituitary Gland; Pro-Opiomelanocortin; RNA, Messenger | 1989 |
[Study of the in vitro effect of MPA on an established cell line from a human renal cell carcinoma].
Topics: Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Cycle; Cell Line; Cells, Cultured; Colony-Forming Units Assay; DNA Replication; Flow Cytometry; Humans; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; RNA, Neoplasm; Tumor Stem Cell Assay | 1985 |
[Complete regression of pulmonary metastases from renal cell carcinoma induced by medroxyprogesterone and streptococcal preparation: a case presentation].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biological Products; Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Picibanil | 1985 |
Hormonal effects of high dose medroxyprogesterone acetate treatment in males with renal or prostatic adenocarcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Dehydroepiandrosterone; Estradiol; Follicle Stimulating Hormone; Hormones; Humans; Hydrocortisone; Kidney Neoplasms; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prolactin; Prostatic Neoplasms; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone | 1988 |
Complete regression of skeletal metastases from hypernephroma after angioinfarction and medroxyprogesterone acetate therapy.
Topics: Bone Neoplasms; Brain Neoplasms; Carcinoma, Renal Cell; Combined Modality Therapy; Embolization, Therapeutic; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Remission Induction; Renal Artery | 1988 |
Endocrinological effects of treatment with high doses of medroxyprogesterone acetate in patients with renal or prostatic adenocarcinoma.
Topics: Adenocarcinoma; Androgens; Antineoplastic Agents; Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Prostatic Neoplasms; Sex Hormone-Binding Globulin | 1988 |
Infarction-nephrectomy for metastatic renal carcinoma. Southwest oncology group study.
Topics: Carcinoma, Renal Cell; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Injections, Intramuscular; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Nephrectomy; Renal Artery; Time Factors | 1985 |
Treatment of renal cell carcinoma with renal infarction, delayed nephrectomy, medroxyprogesterone, and xenogeneic immune RNA.
Topics: Carcinoma, Renal Cell; Combined Modality Therapy; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Immunization, Passive; Kidney Neoplasms; Male; Medroxyprogesterone; Middle Aged; Nephrectomy; Renal Artery; Time Factors | 1985 |